沃华医药
(002107)
| 流通市值：42.00亿 | | | 总市值：42.42亿 |
| 流通股本：5.71亿 | | | 总股本：5.77亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 588,844,408.64 | 393,349,512.77 | 219,045,381.55 | 816,952,424.84 |
| 营业收入 | 588,844,408.64 | 393,349,512.77 | 219,045,381.55 | 816,952,424.84 |
| 二、营业总成本 | 481,393,835.28 | 315,038,296 | 177,276,991.23 | 721,298,250.06 |
| 营业成本 | 131,613,283.13 | 87,147,077.98 | 48,268,449.66 | 201,114,648.37 |
| 税金及附加 | 10,652,223.46 | 6,977,293.28 | 3,817,327.3 | 14,347,228.55 |
| 销售费用 | 270,042,429.69 | 173,492,506.54 | 100,433,506.95 | 407,251,977.03 |
| 管理费用 | 45,072,763.85 | 31,133,408.22 | 16,931,758.39 | 66,129,923.71 |
| 研发费用 | 24,520,113.07 | 16,645,328.79 | 8,014,142.01 | 36,394,805.27 |
| 财务费用 | -506,977.92 | -357,318.81 | -188,193.08 | -3,940,332.87 |
| 其中:利息费用 | 24,217.47 | 18,767.58 | 10,042.82 | 62,306.1 |
| 其中:利息收入 | 556,384.7 | 394,156.78 | 210,969.29 | 4,042,283.59 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | - | - | - | 1,763,146.58 |
| 资产处置收益 | 1,502.59 | 1,502.59 | - | - |
| 资产减值损失(新) | -608,185.9 | -542,347.16 | 27,283.79 | -1,950,661.77 |
| 信用减值损失(新) | 202,933.16 | 730,014.16 | 616,524.77 | 3,113,190.19 |
| 其他收益 | 2,926,806.69 | 2,209,673.86 | 1,110,481.55 | 5,018,194.16 |
| 四、营业利润 | 109,973,629.9 | 80,710,060.22 | 43,522,680.43 | 103,598,043.94 |
| 加:营业外收入 | 451,544.81 | 420,480.94 | 389,712.07 | 494,594.69 |
| 减:营业外支出 | 125,697.71 | 29,225.01 | 20,827.32 | 1,713,065.74 |
| 五、利润总额 | 110,299,477 | 81,101,316.15 | 43,891,565.18 | 102,379,572.89 |
| 减:所得税费用 | 12,804,138.4 | 10,068,197.23 | 5,440,686.82 | 13,588,501.27 |
| 六、净利润 | 97,495,338.6 | 71,033,118.92 | 38,450,878.36 | 88,791,071.62 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 97,495,338.6 | 71,033,118.92 | 38,450,878.36 | 88,931,033.05 |
| 终止经营净利润 | - | - | - | -139,961.43 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 92,654,514.94 | 67,566,295.15 | 36,648,737.04 | 95,715,292.65 |
| 少数股东损益 | 4,840,823.66 | 3,466,823.77 | 1,802,141.32 | -6,924,221.03 |
| 扣除非经常损益后的净利润 | 90,645,945.13 | 65,959,000.12 | 35,743,706.1 | 92,106,702.57 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.16 | 0.12 | 0.06 | 0.17 |
| (二)稀释每股收益 | 0.16 | 0.12 | 0.06 | 0.17 |
| 九、综合收益总额 | 97,495,338.6 | 71,033,118.92 | 38,450,878.36 | 88,791,071.62 |
| 归属于母公司股东的综合收益总额 | 92,654,514.94 | 67,566,295.15 | 36,648,737.04 | 95,715,292.65 |
| 归属于少数股东的综合收益总额 | 4,840,823.66 | 3,466,823.77 | 1,802,141.32 | -6,924,221.03 |
| 公告日期 | 2026-10-10 | 2026-07-16 | 2026-04-08 | 2026-01-20 |
| 审计意见(境内) | | | | 标准无保留意见 |